Emerging Markets--China Primary Research Methodology

Our primary research with Chinese physicians for each disease is informed by secondary sources that detail the Chinese healthcare system, pharmaceutical markets, and disease-specific treatment guidelines. Sources are accurately translated from Chinese.

For each indication, we will be conducting in-depth qualitative interviews with 25-30 Chinese physicians of the appropriate specialties in the key urban areas of Shanghai, Beijing, Guangzhou, and Shenzhen. Interviews are conducted in person in Chinese to provide the truest understanding of the physicians’ perspective.

Topics will include:

• Key unmet needs in diagnosis and treatment
• Current Treatment Practices
• Attitudes towards changing treatment practices
• Drivers of treatment choice and regional variation of treatment
• Patient attitudes and willingness to pay for branded medicines

The qualitative interviews will inform our survey of an additional 90 Chinese physicians in Shanghai, Beijing, and Guangzhou.

Topics will include

• Patient access to Western medicine
• Patient access and willingness to buy Western branded pharmaceuticals
• Patient presentation behavior and attitudes
• Screening practices
• Treatment choice and drivers
• Role of traditional Chinese medicine
• Unmet needs in diagnosis and treatment

Additional Expert Sources

The research supporting our Emerging Markets—China report series also includes insight from contacts within a number of organizations and agencies, including:

• Contacts in leading Chinese hospitals, through Millennium Research Group, a Decision Resources Company
• Chinese Center for Disease Control and Prevention (CDC)
• Ministry of Health, People’s Republic of China
• Harvard School of Public Health
• Canadian Program on Genomics and Global Health
• and other commercial organizations based in China, including CROs, financial firms, and biopharma companies